Rational Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-328
| Closed | -$181K | – | 197 |
|
|
2024
Q2 | $181K | Buy |
+328
| New | +$188K | 0.02% | 118 |
|
|
2023
Q3 | – | Sell |
-3,570
| Closed | -$1.86M | – | 306 |
|
|
2023
Q2 | $1.86M | Buy |
3,570
+300
| +9% | +$162K | 0.15% | 62 |
|
|
2023
Q1 | $1.88M | Sell |
3,270
-750
| -19% | -$423K | 0.15% | 60 |
|
|
2022
Q4 | $2.21M | Sell |
4,020
-180
| -4% | -$95.4K | 0.18% | 46 |
|
|
2022
Q3 | $2.13M | Buy |
4,200
+1,200
| +40% | +$672K | 0.17% | 42 |
|
|
2022
Q2 | $1.63M | Buy |
3,000
+550
| +22% | +$303K | 0.12% | 57 |
|
|
2022
Q1 | $1.45M | Buy |
+2,450
| New | +$1.41M | 0.09% | 67 |
|
|
2021
Q1 | – | Sell |
-2,100
| Closed | -$978K | – | 236 |
|
|
2020
Q4 | $978K | Buy |
2,100
+2,097
| +69,900% | +$983K | 0.26% | 102 |
|
|
2020
Q3 | $1K | Sell |
3
-5
| -63% | -$2.07K | ﹤0.01% | 568 |
|
|
2020
Q2 | $3K | Buy |
+8
| New | +$2.68K | ﹤0.01% | 464 |
|
|
2020
Q1 | – | Sell |
-91
| Closed | -$30K | – | 481 |
|
|
2019
Q4 | $30K | Sell |
91
-10
| -10% | -$3.03K | 0.01% | 393 |
|
|
2019
Q3 | $29K | Sell |
101
-8,058
| -99% | -$2.31M | 0.01% | 423 |
|
|
2019
Q2 | $2.4M | Sell |
8,159
-2,416
| -23% | -$665K | 0.85% | 22 |
|
|
2019
Q1 | $2.9M | Buy |
10,575
+10,183
| +2,598% | +$2.53M | 0.78% | 34 |
|
|
2018
Q4 | $88K | Sell |
392
-12,641
| -97% | -$2.97M | 0.03% | 241 |
|
|
2018
Q3 | $3.18M | Buy |
13,033
+12,859
| +7,390% | +$2.96M | 0.76% | 33 |
|
|
2018
Q2 | $36K | Sell |
174
-46
| -21% | -$9.76K | 0.02% | 285 |
|
|
2018
Q1 | $45K | Buy |
+220
| New | +$46.2K | 0.02% | 286 |
|
|
2016
Q3 | – | Sell |
-5,000
| Closed | -$739K | – | 306 |
|
|
2016
Q2 | $739K | Buy |
+5,000
| New | +$738K | 0.51% | 50 |
|
|
2015
Q3 | $49K | Hold |
403
| – | – | 0.02% | 261 |
|
|
2015
Q2 | $52K | Hold |
403
| – | – | 0.02% | 254 |
|
|
2015
Q1 | $54K | Sell |
403
-264
| -40% | -$34K | 0.01% | 253 |
|
|
2014
Q4 | $84K | Buy |
+667
| New | +$81.1K | 0.02% | 280 |
|
|
2013
Q4 | $434K | Sell |
3,897
-9,286
| -70% | -$923K | 0.04% | 364 |
|
|
2013
Q3 | $1.22M | Sell |
13,183
-26,279
| -67% | -$2.38M | 0.09% | 299 |
|
|
2013
Q2 | $3.34M | Buy |
+39,462
| New | +$3.28M | 0.28% | 116 |
|
Other funds holding TMO
Rational Advisors's TMO Position: Q3 2024 in Review
Rational Advisors sold out of Thermo Fisher Scientific (TMO) in Q3 2024, closing a stake of 328 shares — an estimated $181K sold.
Rational Advisors first reported a position in TMO in Q2 2013 and held it in 26 quarters. The position peaked at $3.34M in Q2 2013. 2,568 funds tracked by Wall St. Rank hold TMO as of Q3 2024.
- Rational Advisors reported no remaining Thermo Fisher Scientific position as of Q3 2024 after selling out during the quarter.
- Rational Advisors sold 328 Thermo Fisher Scientific shares in Q3 2024, an estimated $181K.
- Rational Advisors first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 26 quarters.
- Rational Advisors's Thermo Fisher Scientific position peaked at $3.34M in Q2 2013.
- 2,568 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2024.
Based on Rational Advisors's 13F filing for Q3 2024, filed 30 Oct 2024.